Receive FREE Newsletter
Advanced Search
+

DB Schenker partners with SkyCell on temperature-regulated containers for Covid vaccines

skycell-1
By

Milestone agreement for the lease of SkyCell’s hybrid pharma containers • Containers maintain constant temperatures for more than a week • Suitable for all Covid-19 vaccines on the market

DB Schenker increases response to the pandemic by signing a Master Lease Agreement (MLA) with SkyCell. The ...

To read this article you need to subscribe.

Help us to continue to invest in award-winning independent journalism. For an introductory offer of just £70 a year, or £10 per month, get access to all our daily news stories and opinion. If you are already a registered user, please login below with your current account's email and password to subscribe. If you are not registered and want to subscribe, please register below to subscribe.
Current subscriber
New subscriber

Comment on this article

You must be logged in to post a comment.

    Related Stories

    Topics

    coronavirus DB Schenker SkyCell vaccines